CYP cynata therapeutics limited

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-6

  1. 3,929 Posts.
    lightbulb Created with Sketch. 2781
    Hi Bedger, what am I missing? Msb trial was pediatric and this trial was for adults. So quoting the % difference is of no value??
    Great to see Rux getting its arse kicked though.
    What class of disease were the 60% survivors? As Rem-l appears most effective the most severe cases.

    Genuine query , not stirring the pot

    Reg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.